Risk-Stratifying Patients with a TIA - Frankly Speaking Ep 226

<p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Credits: 0.25 AMA PRA Category 1 Credit™</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> CME/CE Information and Claim Credit: <a href= "https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-208" target="_blank" rel= "noopener">https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226</a></p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA.</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Episode References and Resource Links:</p> <ul> <li style="font-family: Calibri; font-size: 11pt;">Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49</li> </ul> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Guest: Alan Ehrlich MD, FAAFP</p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;">  </p> <p style="margin: 0in; font-family: Calibri; font-size: 11.0pt;"> Music Credit: Richard Onorato</p>